{"product_id":"current-concepts-in-hematopathology-2022-videos","title":"Current Concepts in Hematopathology 2022 ( VIDEOS)","description":"\u003cp\u003e\u003cspan style=\"color: #1b1919;font-size: 28px\"\u003eCurrent Concepts in Hematopathology 2022 ( VIDEOS)\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" role=\"tabpanel\" aria-labelledby=\"tab-title-description\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv id=\"tab-description\" class=\"panel entry-content active\"\u003e\n\u003cdiv class=\"woocommerce-tabs wc-tabs-wrapper container tabbed-content\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" role=\"tabpanel\" aria-labelledby=\"tab-title-description\"\u003e\n\u003cdiv id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" role=\"tabpanel\" aria-labelledby=\"tab-title-description\"\u003e\n\u003cdiv class=\"single-main-content\"\u003e\n\u003cp\u003eIn this online CME program, leaders in diagnostic pathology deliver in-depth discussions of microscopic evaluation of hematolymphoid disorders, as well as the appropriate use of a broad range of ancillary studies. \u003cem\u003eCurrent Concepts in Hematopathology\u003c\/em\u003e delivers continuing medical education insights, including:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ecommon pitfalls in the morphologic interpretation and immunophenotyping of hematolymphoid proliferations\u003c\/li\u003e\n\u003cli\u003eapproaches to cases that do not conform to WHO diagnostic categories\u003c\/li\u003e\n\u003cli\u003euse of evidence-based guidelines, cytogenetics, and molecular testing to inform diagnosis\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003cp\u003e\u003cem\u003eUpon completion of this activity, participants will be able to:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCorrectly use morphologic criteria and cost-effectively use ancillary studies to diagnose a broad range of lymph node and bone marrow pathologies\u003c\/li\u003e\n\u003cli\u003eApply evidence-based criteria to the diagnosis of myeloid and lymphoid neoplasms\u003c\/li\u003e\n\u003cli\u003eDiagnose challenging cases that do not readily conform to well-established entities\u003c\/li\u003e\n\u003cli\u003eEvaluate and distinguish hematolymphoid malignancies from non-neoplastic mimics of malignancy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTarget Audience\u003c\/h3\u003e\n\u003cp\u003eThis course is targeted to specialty physicians who practice in pathology.\u003c\/p\u003e\n\u003ch4\u003eTOPICS \/ SPEAKERS\u003c\/h4\u003e\n\u003cdiv class=\"product-tab-content\"\u003e\n\u003cdiv id=\"tab-speaker\"\u003e\n\u003cul\u003e\n\u003cli\u003eNodal Small B-Cell Lymphomas – \u003cem\u003eElizabeth A. Morgan, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePlasma Cell Neoplasms and Lymphoplasmacytic Lymphoma – \u003cem\u003eValentina Nardi, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eRobert P. Hasserjian, MD – Moderator, Elizabeth A. Morgan, MD and Valentina Nardi, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eImmunodeficiency and Viral-Associated Lymphoproliferations – \u003cem\u003eJudith A. Ferry, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eUpdates in Cutaneous Lymphomas – \u003cem\u003eSam Sadigh, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eElizabeth A. Morgan, MD – Moderator, Judith A. Ferry, MD and Sam Sadigh, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eWHO Update – Follicular Lymphoma and Related Entities – \u003cem\u003eAbner Louissaint Jr., MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eDiffuse Large B-Cell Lymphoma Subtypes – \u003cem\u003eScott B. Lovitch, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eMarian H. Harris, MD – Moderator, Abner Louissaint Jr, MD, PhD and Scott B. Lovitch, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBurkitt Lymphoma and High-Grade B-Cell Lymphomas – A Practical Guide and Update – \u003cem\u003eAliyah R. Sohani, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eReactive Lymphadenopathies and Castleman Disease – \u003cem\u003eYasodha Natkunam, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eRobert P. Hasserjian, MD – Moderator, Yasodha Natkunam, MD, PhD and Aliyah R. Sohani, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eApproach to Peripheral Smear Review – \u003cem\u003eElizabeth Courville, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMyelodysplastic Syndrome and Its Differential Diagnosis – \u003cem\u003eRobert P. Hasserjian, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eElizabeth A. Morgan, MD – Moderator, Elizabeth Courville, MD and Robert P. Hasserjian, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAcute Myeloid Leukemia and Acute Leukemias of Ambiguous Lineage – \u003cem\u003eOlga K. Weinberg, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAcute Lymphoblastic Leukemia – \u003cem\u003eMarian H. Harris, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eRobert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD and Olga K. Weinberg, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eEosinophilia and Mastocytosis – \u003cem\u003eOlga Pozdnyakova, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMyelodysplastic\/Myeloproliferative Neoplasms – \u003cem\u003eRobert P. Hasserjian, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eMarian H. Harris, MD, PhD – Moderator, Robert P. Hasserjian, MD and Olga Pozdnyakova, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eInterpreting Flow Cytometry Minimal Residual Disease in Acute Leukemia – \u003cem\u003eSa A. Wang, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePractical Interpretation of Molecular Testing in Myeloid Neoplasms – \u003cem\u003eAnnette S. Kim, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eElizabeth A. Morgan, MD – Moderator, Annette S. Kim, MD, PhD and Sa A. Wang, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eChallenges in the Diagnosis of Hodgkin Lymphomas – \u003cem\u003eMarian H. Harris, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePrimary Mediastinal Large B-Cell and Grey-Zone Lymphomas – \u003cem\u003eScott J. Rodig, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eRobert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD and Scott J. Rodig, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eIndolent T-Cell Disorders – \u003cem\u003eKathleen H. Burns, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNodal T-Cell Lymphomas – \u003cem\u003eRoberto Chiarle, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eMarian H. Harris, MD, PhD – Moderator, Kathleen H. Burns, MD, PhD and Roberto Chiarle, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eHistiocytic and Dendritic Cell Neoplasms – \u003cem\u003eElizabeth A. Morgan, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eIgG4-Related Disease and Lymphadenopathy – \u003cem\u003eJacob R. Bledsoe, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBlastic Plasmacytoid Dendritic Cell Neoplasm – \u003cem\u003eGabriel K. Griffin, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eMarian H. Harris, MD, PhD – Moderator, Jacob R. Bledsoe, MD, Gabriel K. Griffin, MD and Elizabeth A. Morgan, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eInherited Predisposition to Myeloid (and Hematological) Malignancies – \u003cem\u003eMark D. Fleming, MD, DPhil\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSpleen Pathology – \u003cem\u003eLawrence R. Zukerberg, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eQuestion \u0026amp; Answer – \u003cem\u003eElizabeth A. Morgan, MD – Moderator, Mark D. Fleming, MD, DPhil and Lawrence R. Zukerberg, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDate of Original Release:\u003c\/strong\u003e \u003cstrong\u003eJune 30, 2022\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTermination Date:\u003c\/strong\u003e June 30, 2025\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"related related-products-wrapper product-section\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954656317538,"sku":"MED-AMB07657","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Current-Concepts-in-Hematopathology-2022-VIDEOS.jpg?v=1779381784","url":"https:\/\/meducourse.com\/products\/current-concepts-in-hematopathology-2022-videos","provider":"Meducourse","version":"1.0","type":"link"}